Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium (EC-MPS) or mycophenolate mofetil (MMF) at 12 months post-transplant

被引:0
|
作者
Segovia, Javier [1 ]
Gerosa, Gino
Almenar, Luis [2 ]
Livi, Ugolino [3 ]
Vigano, Mario [4 ]
Arizon, Jose Maria [5 ]
Yonan, Nizar [6 ]
机构
[1] Hosp Univ Puerta Hierro, Unidad Transplante Cardiac, Madrid, Spain
[2] Hosp La Fe, E-46009 Valencia, Spain
[3] Univ Hosp, Dept Cardiopulm Sci, Udine, Italy
[4] Univ Hosp, Cardiosurg Div, Pavia, Italy
[5] Hosp Reina Sofia, Unidad Transplante Cardiac, Cordoba, Spain
[6] Wythenshawe Hosp, Cardiothorac Transplantat Ctr, Manchester M23 9LT, Lancs, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:6 / 6
页数:1
相关论文
共 50 条
  • [1] Dose reductions in heart transplant patients receiving enteric-coated mycophenolate sodium (EC-MPS) or mycophenolate mofetil (MMF): Comparison of clinical impact at 12 months post-transplant.
    Di Salvo, Thomas G.
    Kobashigawa, John C.
    Renlund, Dale A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 348 - 348
  • [2] Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation
    Segovia, Javier
    Gerosa, Gino
    Almenar, Luis
    Livi, Ugolino
    Vigano, Mario
    Arizon, Jose Maria
    Yonan, Nizar
    Di Salvo, Thomas G.
    Renlund, Dale G.
    Kobashigawa, Jon A.
    [J]. CLINICAL TRANSPLANTATION, 2008, 22 (06) : 809 - 814
  • [3] Conversion of Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) Ameliorates GI Symptoms in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Yelochan, Barbara
    Durant, Stephanie
    Lopez-Solis, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 531
  • [4] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [5] CONVERSION OF MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC COATED MYCOPHENOLATE SODIUM (EC-MPS) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Matsuda-Abedini, Mina
    Kiang, Tony K. L.
    Ensom, Mary H. H.
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 131 - 131
  • [6] EXPOSURE TO MYCOPHENOLIC ACID ON MYCOPHENOLATE MOFETIL (MMF) AND ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN KIDNEY PANCREAS TRANSPLANT PATIENTS WITH SEVERE GASTROPARESIS
    Belliere, Julie
    Gandia, Peggy
    Melki, Vincent
    Duffas, Jean Pierre
    Rostaing, Lionel
    Kamar, Nassim
    Esposito, Laure
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
  • [7] USE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN LIVER TRANSPLANT PATIENTS
    de Vera, Michael E.
    Lopez, Roberto
    Yelochan, Barbara
    Hope, Laurie
    Marcos, Amadeo
    Fontes, Paulo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S112
  • [8] Enteric-coated mycophenolate sodium (EC-MPS) vs mycophenolate mofetil (MMF) in de novo heart transplant patients: 6-month efficacy and safety results.
    Kobashigawa, JA
    Davis, SF
    Renlund, DG
    Eisen, H
    Miller, L
    Lehmkuhl, H
    Gambino, A
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [9] Enteric-coated mycophenolate sodium (EC-MPS) is comparable to mycophenolate mofetil in de novo heart transplant patients. Twelve months efficacy and safety results.
    Kobashigawa, JA
    Gerosa, G
    Caforio, A
    Renlund, DG
    Ross, H
    Yonan, N
    Hummel, M
    Segovia, J
    Almenar, L
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 244 - 244
  • [10] Enteric-Coated Mycophenolate Sodium (EC-MPS) Has Less GI Side Effects Compared to Mycophenolate Mofetil (MMF) in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Kikla, Stephenie
    Fedorek, Sheila
    Durant, Stephanie
    Lopez, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 533 - 533